Germany’s BioNTech Settles With US Agency, UPenn Over COVID Vaccine Royalties
Insurance Journal - Dec 27, 2024
BioNTech has entered into two separate settlement agreements with the U.S. National Institutes of Health and the University of Pennsylvania over the payment of royalties related to its COVID-19 vaccine, the company said in filings. The German company, which partners …...
Recommended Articles
Posted: Oct 10, 2025
This post is part of a series sponsored by Risk & Insurance Education Alliance. In an industry w...
Posted: Oct 10, 2025
Special Contingency Risks (SCR), a WTW business, has launched an Enhanced Victim Support insurance e...
Posted: Oct 10, 2025
Higginbotham has acquired Lubbock, Texas-based Stephens Insurance Services, a benefits specialist. T...